Other functions - preclinical efficacy and intermediate endpoint biomarkers

Ended Awarded Last action

Contract number
HHSN261201200015I
Awardee
Awarding agency
Task orders
6 $2,632,795 obligated

Award facts

Opportunity
Combined order value
$2,632,795 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 26% used
$9,950,000.00
Maximum order
$9,950,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 5 offers Negotiated Proposal / Quote
Pricing
Order Dependent (IDV only)

Award details come from SAM.gov/FPDS.

Task orders

Task order Ordering agency Obligated Awarded
HHSN2610006 title: modulation of mirna expression in blood or other biological fluids compared with tissue levels in… HHSN26100006 National Cancer Institute (NIH) $567,649
Effects of chemopreventive agents on biomarkers related to lung tumorigenesis: alterations in 'at risk'… HHSN26100004 National Cancer Institute (NIH) $611,204
Efficacy of eldecalcitol (ED-71) in colorectal cancer prevention in APC-min mice model HHSN26100005 National Cancer Institute (NIH) $303,650
Other functions - modulation of cigarette smoke-induced alterations of microrna expression and lung tumors in mice… HHSN26100003 National Cancer Institute (NIH) $598,689
Other functions - preclinical efficacy and intermediate endpoint biomarkers HHSN26100002 National Cancer Institute (NIH) $547,860
Other functions - preclinical efficacy and intermediate endpoint biomarkers-contract orientation meeting with NCI… HHSN26100001 National Cancer Institute (NIH) $3,743

Transactions

Action Obligated Date
Other Administrative Action 3 $0
Other Administrative Action 2 $0
Other Administrative Action 1 · Preclinical efficacy and intermediate endpoint biomarkers $0
Original award $0

Quick answers

Who was awarded contract HHSN261201200015I?

HHSN261201200015I was awarded to The Institute For Cancer Research by National Cancer Institute (National Institutes of Health) on September 20, 2012.

How much is contract HHSN261201200015I worth?

Orders under HHSN261201200015I have obligated $2,632,795. HHSN261201200015I's own ceiling is $9,950,000. A single order can be worth up to $9,950,000.

How many orders have been placed under contract HHSN261201200015I?

6 orders have been placed under HHSN261201200015I, the latest on September 18, 2014.

Who can order from contract HHSN261201200015I?

HHSN261201200015I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Is contract HHSN261201200015I part of a contract vehicle?

Yes. HHSN261201200015I is part of Preclinical Efficacy and Intermediate Endpoint Biomarkers.

Was contract HHSN261201200015I competed?

The extent of competition for HHSN261201200015I was full and open competition. The government received 5 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login